Derek T. Chalmers - Sep 7, 2021 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role: President & CEO, Director
Signature: /s/Darren DeStefano, Attorney-in-Fact
Stock symbol: CARA
Transactions as of: Sep 7, 2021
Transactions value $: -$309,400
Form type: 4
Date filed: 9/9/2021, 04:48 PM
Previous filing: Sep 1, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CARA	Common Stock	Sale	-$309K	-20K	-1.98%	$15.47^*	991K	Sep 7, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.34 to $15.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.34 to $15.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.